In a live virtual event, Thomas C. Krivak, MD, reviewed the key studies of PARP inhibitor and bevacizumab maintenance in ...

Olaparib, an inhibitor of poly (ADP-ribose) polymerase (PARP), has demonstrated promising outcomes in treating HER2-negative early-stage breast cancer with BRCA mutations. However, a comprehensive ...

President Donald Trump has ordered federal officials to scour monuments, memorials and statues to remove language he says may "inappropriately disparage Americans," as part of his efforts to fight ...